XML 14 R4.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Condensed Statements of Operations and Comprehensive (Loss) Income - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Total revenue $ 10,636 $ 15,747 $ 25,066 $ 30,593
Total cost of sales 5,420 6,554 11,690 12,970
Gross profit 5,216 9,193 13,376 17,623
Operating expenses:        
Research and development 3,457 2,708 6,875 5,907
General and administrative 3,254 3,507 7,290 6,727
Sales and marketing 1,324 1,355 2,630 2,670
Total operating expenses 8,035 7,570 16,795 15,304
(Loss) income from operations (2,819) 1,623 (3,419) 2,319
Interest expense       (63)
Other income, net 393 2,262 791 2,390
Net (loss) income before income taxes (2,426) 3,885 (2,628) 4,646
Income tax (expense) benefit (76)   (76)  
Net (loss) income and comprehensive income $ (2,502) $ 3,885 $ (2,704) $ 4,646
Net (loss) income per common share, Basic $ (0.12) $ 0.19 $ (0.13) $ 0.23
Net (loss) income per common share, Diluted $ (0.12) $ 0.18 $ (0.13) $ 0.22
Weighted-average shares of common stock outstanding, basic 21,566,863 20,657,404 21,409,611 20,554,769
Weighted average shares of common stock outstanding, Diluted 21,566,863 21,234,253 21,409,611 21,068,059
Product sales        
Total revenue $ 9,887 $ 13,406 $ 20,747 $ 27,183
Total cost of sales 5,235 6,090 11,238 12,213
Licensing, royalty, patent, and other revenue        
Total revenue 749 2,341 4,319 3,410
Total cost of sales $ 185 $ 464 $ 452 $ 757